Aerie Pharmaceuticals IncMost Recent.Earnings ReportWhat Analysts Recommend for Array BioPharma StockAs of August 15, analysts’ target price for ARRY is $23.57, which implies a ~71.7% return over the next 12 months based on the stock’s August 14 price of $13.73.
.Earnings ReportWhat Analysts Recommend for Array BioPharma StockAs of August 15, analysts’ target price for ARRY is $23.57, which implies a ~71.7% return over the next 12 months based on the stock’s August 14 price of $13.73.
